Particulars |
|
|
|
Company Name
| Concord Drugs Ltd
| Year End
| 202303
|
Full Year |
Equity (₹ Cr.) |
10.00 |
B.V. (₹) |
35.40 |
Sales(₹ Cr.) |
51.31 |
NP (₹ Cr.) |
0.89 |
NP Var (%) |
-44.00 |
Div% |
0.00 |
CPS(₹) |
2.50 |
EPS (₹) |
0.90 |
Traded Value(₹ Lakhs) |
1.92 |
52 Week High |
62.00 |
52 Week Low |
26.00 |
Price BSE |
37.00 |
Price NSE |
0.00 |
Market Capital (₹ Cr.) |
36.73 |
P/C Ratio |
14.80 |
P/E Ratio |
41.50 |
Price Vs.BV |
1.05 |
|
Latest Quarter |
Year End |
202312 |
Sales (₹ Cr.) |
12.62 |
NP(₹ Cr.) |
-0.24 |
NP Var % |
-153.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
55.15 |
OPM |
6.97 |
NP |
0.82 |
NP Var (%) |
-0.91 |
EPS |
0.84 |
PE |
43.73 |
|
|